Vimarsana
Biggest News Aggregation in the World

Page 16 - Cycle Day News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cycle Day. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cycle Day Today - Breaking & Trending Today

OP: Theme-less Market, Ripe with Stock Pickers - Vimarsana News

OP: Theme-less Market, Ripe with Stock Pickers

Tuesday’s Session was Cycle Day 2 (CD2): Price violated CD1 Low (4141.75) with a continuation trend lower during RTH fulfilling 4115, “down-range” objective. Range was 56.75 handles on 1.661M contracts exchanged.  … This leads us into Cycle Day 3 (CD3): Price is currently well below CD1 Low (4141.75) and typically has strong odds of recovering this level during Cycle Day 3 trading. Failure to recover would be marked as a “Statistical Cycle Failure” which only occurs 9% of the time tracked over twelve years of data. As such estimated scenarios to consider for today’s trading. 1...

OP: S&P 500 Notches Another New High - Vimarsana News

OP: S&P 500 Notches Another New High

Tuesday’s Session was Cycle Day 3 (CD3): Price consolidated throughout the session before pushing higher to All-Time Contract High. Price settled above its Value Area High (4132.25). Range was 38.50 handles on 1.04M contracts exchanged.  … This leads us into Cycle Day 1 (CD1): Normal for CD1 is an expectation of a decline measuring an average of 4088. Volatility Index (VIX) has registered a reading with a 16 handle, as bulls are solidly in control, so any decline may be relatively shallow. As such, estimated scenarios to consider for today’s trading: 1.) Price sustains a bid above 41...

OP: S&P Futures Close Lower After Monday's 17th New High - Vimarsana News

OP: S&P Futures Close Lower After Monday's 17th New High

Tuesday’s Session was Cycle Day 1 (CD1): Price only produced a shallow decline (4052.25) during the overnight session, while RTH experienced a bit more confusion on direction after hitting early session highs. Range was 23.75 handles on 1.233M contracts exchanged.  … This leads us into Cycle Day 2 (CD2): Expectation for this cycle day is more consolidation, perhaps with a wider range should volatility increase. Volatility Index (VIX) has been hovering with an 18 handle, which makes for intra-day trading challenging with narrowing of the range. As such estimated scenarios to consider fo...

OP: All Eyes on the Fed - Vimarsana News

OP: All Eyes on the Fed

Tuesday’s Session was Cycle Day 1 (CD1): Price continued in rally-mode until excess momentum fulfilled Cycle Penetration objectives, then reversing direction, selling down to yesterday’s late day breakout (3943), and finally settling neutral mid-range. Range was 28 handles on 1.332M contracts exchanged.  … This leads us into Cycle Day 2 (CD2): Having closed mid-range, typical price action expected would be for continued consolidation of recent rally. As such, there are two estimated scenarios to consider for today’s trading. 1.) Price sustains a bid above 3960, initially targets 39...

OP: Is Tesla the New Bellwether Stock? - Vimarsana News

OP: Is Tesla the New Bellwether Stock?

Tuesday’s Session was Cycle Day 2 (CD2): Price consolidation during Globex Session led to continuation rally during RTH Session fulfilling CD2 Penetration Objective. Late day profit-taking pushed price to close near Value Area Low (3871). Range was 75 handles on 1.627M contracts exchanged.  … This leads us into Cycle Day 3 (CD3): Cycle Targets have been fulfilled, so as such the decline can begin at any time. We’ll mark today as a “wild-card”, as price is free to move in any direction. As such, there are two estimated scenarios to consider for today’s trading. 1.) Price sustain...